MRC1 and hyperinsulinemic hypoglycemia, familial, 4: As women with EC with MMR deficiency or MSI (hypermutated) may benefit from immunotherapy, consideration should be given for MMR deficiency testing for women with EC who are candidates for chemotherapy.